Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:1118-1123
Published online before print March 24, 2003, doi: 10.1161/01.HYP.0000064345.33807.57
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/5/1118    most recent
01.HYP.0000064345.33807.57v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, S.-i.
Right arrow Articles by Saku, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, S.-i.
Right arrow Articles by Saku, K.
Related Collections
Right arrow Receptor pharmacology
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction

(Hypertension. 2003;41:1118.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Transactivation of KDR/Flk-1 by the B2 Receptor Induces Tube Formation in Human Coronary Endothelial Cells

Shin-ichiro Miura; Yoshino Matsuo; Keijiro Saku

From the Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.

Correspondence to Shin-ichiro Miura, Department of Cardiology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan. E-mail miuras{at}cis.fukuoka-u.ac.jp

Endothelial cells (ECs) are the critical cellular element responsible for postnatal angiogenesis. Vascular endothelial growth factor (VEGF) stimulates angiogenesis via the activation of kinase insert domain–containing receptor/fetal liver kinase-1 (KDR/Flk-1) in ECs. In addition, transactivation of KDR/Flk-1 by the bradykinin (BK) B2 receptor induces the activation of endothelial nitric oxide synthase (eNOS). These findings indicate that the precise role of BK in angiogenesis is likely to be more complex than initially thought, and it questions the importance of BK in angiogenic processes. Therefore, we examined whether transactivation by BK induced tube formation. We developed an in vitro model of human coronary artery EC (HCEC) tube formation on a matrix gel. We demonstrated that BK dose-dependently induced tube formation. Although a lower concentration of BK and VEGF did not separately induce tube formation, the formation was induced by a combination of lower concentrations of BK and VEGF, suggesting that VEGF and BK had a synergistic effect. The effect was blocked by a B2 receptor antagonist (HOE140) and specific inhibitors of VEGF receptor tyrosine kinases (Tki) and NOS. In addition, BK induced tyrosine phosphorylation of the KDR/Flk-1 receptor, as did VEGF itself. The transactivation was also blocked by HOE140 and Tki. Our results showed that, in HCECs, stimulation of the B2 receptor leads to the transactivation of KDR/Flk-1, as well as to eNOS activation, which induces tube formation. To our knowledge, this is a novel mechanism in which transactivation of KDR/Flk-1 by a G protein–coupled receptor, B2 receptor, may be a potent signal for tube formation.


Key Words: endothelium • endothelial growth factors • kinase • receptors, bradykinin • nitric oxide




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y.-Y. Yao, H. Yin, B. Shen, R. S. Smith Jr, Y. Liu, L. Gao, L. Chao, and J. Chao
Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3{beta} pathway
Cardiovasc Res, September 4, 2008; (2008) cvn223v2.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-F. Lam, P.-J. Chang, Y.-S. Huang, Y.-H. Sung, C.-C. Huang, M.-W. Lin, Y.-C. Liu, and Y.-C. Tsai
Prolonged Use of High-Dose Morphine Impairs Angiogenesis and Mobilization of Endothelial Progenitor Cells in Mice
Anesth. Analg., August 1, 2008; 107(2): 686 - 692.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Sanchez de Miguel, S. Neysari, S. Jakob, M. Petrimpol, N. Butz, A. Banfi, C. E. Zaugg, R. Humar, and E. J. Battegay
B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart
Cardiovasc Res, July 21, 2008; (2008) cvn170v2.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Greenberg, M. King, W. B. Kiosses, K. Ewalt, X. Yang, P. Schimmel, J. S. Reader, and E. Tzima
The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells
FASEB J, May 1, 2008; 22(5): 1597 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Xu, P. Czerwinski, M. Hortmann, H.-Y. Sohn, U. Forstermann, and H. Li
Protein kinase C {alpha} promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor
Cardiovasc Res, May 1, 2008; 78(2): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Imaizumi, S.-i. Miura, K. Nakamura, Y. Kiya, Y. Uehara, B. Zhang, Y. Matsuo, H. Urata, M. Ideishi, K.-A. Rye, et al.
Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats.
J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1604 - 1612.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Li, T. Kondo, Y. Numaguchi, K. Kobayashi, M. Aoki, N. Inoue, K. Okumura, and T. Murohara
Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis
Hypertension, February 1, 2008; 51(2): 252 - 258.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. L. Petreaca, M. Yao, Y. Liu, K. DeFea, and M. Martins-Green
Transactivation of Vascular Endothelial Growth Factor Receptor-2 by Interleukin-8 (IL-8/CXCL8) Is Required for IL-8/CXCL8-induced Endothelial Permeability
Mol. Biol. Cell, December 1, 2007; 18(12): 5014 - 5023.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Nagai, Y. Oike, K. Izumi-Nagai, T. Koto, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, et al.
Suppression of Choroidal Neovascularization by Inhibiting Angiotensin-Converting Enzyme: Minimal Role of Bradykinin
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2321 - 2326.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Leung, H. Chen, A. M. Stauffer, K. E. Giger, S. Sinha, E. J. Horstick, J. E. Humbert, C. A. Hansen, and J. D. Robishaw
Zebrafish G protein {gamma}2 is required for VEGF signaling during angiogenesis
Blood, July 1, 2006; 108(1): 160 - 166.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Iwase, N. Nagaya, T. Fujii, T. Itoh, H. Ishibashi-Ueda, M. Yamagishi, K. Miyatake, T. Matsumoto, S. Kitamura, and K. Kangawa
Adrenomedullin Enhances Angiogenic Potency of Bone Marrow Transplantation in a Rat Model of Hindlimb Ischemia
Circulation, January 25, 2005; 111(3): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Emanueli, M. B. Salis, S. Van Linthout, M. Meloni, E. Desortes, J.-S. Silvestre, M. Clergue, C. D. Figueroa, S. Gadau, G. Condorelli, et al.
Akt/Protein Kinase B and Endothelial Nitric Oxide Synthase Mediate Muscular Neovascularization Induced by Tissue Kallikrein Gene Transfer
Circulation, September 21, 2004; 110(12): 1638 - 1644.
[Abstract] [Full Text] [PDF]